HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of cathepsin D determinations in human carcinomas by enzyme immunoassay and immunoradiometric assay.

Abstract
Overexpression of cathepsin D in several types of carcinoma in women appears to be associated with a poor clinical course. In this prospective investigation, cathepsin D levels in 170 specimens of normal and neoplastic human tissues were determined simultaneously by enzyme immunoassay (EIA) and immunoradiometric assay (IRMA) to allow comparisons in multicentric studies, such as cooperative clinical trials. Nonmalignant uteri and specially prepared reference powders were also evaluated. Linear regression analysis between the two assays for all specimens [EIA = 0.87(IRMA)-3.18] demonstrated a correlation coefficient (r) of 0.99 (P < 0.001). When malignancies were categorized by the tissue origin (i.e., breast, uterus, ovary, lymph node, and colon), highly significant correlations were also observed (regressions slopes ranged from 0.58 to 1.02). Intra- and interassay controls conducted for the new EIA procedure gave CV% ranging from 4.4 to 10.2, which was similar to the IRMA test for cathepsin D. The results of both assays correlated well and were highly reproducible. Either assay may be used with confidence that comparable cathepsin D values will be obtained in a wide range of tissue biopsies.
AuthorsR M Shaheen, S Miseljic, D L Doering, J L Wittliff
JournalJournal of clinical laboratory analysis (J Clin Lab Anal) Vol. 9 Issue 6 Pg. 351-8 ( 1995) ISSN: 0887-8013 [Print] United States
PMID8587002 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cathepsin D
Topics
  • Breast Neoplasms (enzymology)
  • Cathepsin D (analysis)
  • Colonic Neoplasms (enzymology)
  • Endometrial Neoplasms (enzymology)
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Immunoenzyme Techniques (statistics & numerical data)
  • Immunoradiometric Assay (methods, statistics & numerical data)
  • Lymphoma (enzymology)
  • Neoplasms (enzymology)
  • Ovarian Neoplasms (enzymology)
  • Prognosis
  • Reproducibility of Results

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: